Search Results - "Yee, Reynold"
-
1
Humoral Immune Response to a Therapeutic Polyvalent Cancer Vaccine After Complete Resection of Thick Primary Melanoma and Sentinel Lymphadenectomy
Published in Journal of clinical oncology (15-01-2003)“…A therapeutic polyvalent cancer vaccine (Canvaxin vaccine; CancerVax Corp, Carlsbad, CA) induces antibodies to a glycoprotein tumor-associated antigen (TA90)…”
Get full text
Journal Article -
2
Tumor-Associated Antigen TA90 Immune Complex Assay Predicts Recurrence and Survival After Surgical Treatment of Stage I-III Melanoma
Published in Journal of clinical oncology (15-02-2001)“…Immune complexes (IC) containing the tumor-associated antigen TA90 can be identified in the sera of melanoma patients. We have shown that an enzyme-linked…”
Get full text
Journal Article -
3
A Comparison of 3 Tumor Markers (MIA, TA90IC, S100B) in Stage III Melanoma Patients
Published in Cancer investigation (01-01-2007)“…Purpose: There is no consensus regarding the optimal tumor markers for melanoma. We compared 3 tumor markers, TA90-immune complex (TA90IC), melanoma-inhibiting…”
Get full text
Journal Article -
4
CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancer
Published in Annals of surgical oncology (01-06-2001)“…The immunogenicity of the polyvalent tumor cell vaccine CancerVax has been correlated with the survival of patients receiving active immunotherapy for…”
Get full text
Journal Article -
5
Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors
Published in Journal of the American College of Surgeons (2004)“…Standard prognostic factors, including precise staging of the regional lymph nodes, cannot accurately determine which early-stage melanomas will metastasize…”
Get full text
Journal Article -
6
Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma?
Published in Annals of surgical oncology (01-04-2000)“…Although the presence of tumor cells in the blood of patients with metastatic melanoma suggests widely disseminated disease, many of these patients enjoy…”
Get full text
Journal Article -
7
Serum TA90 Immune Complex Assay Can Predict Outcome After Resection of Thick (>=4 mm) Primary Melanoma and Sentinel Lymphadenectomy
Published in Annals of surgical oncology (01-03-2002)Get full text
Journal Article -
8
Tumor‐associated antigen TA‐90 immune complex assay predicts subclinical metastasis and survival for patients with early stage melanoma
Published in Cancer (01-10-1998)“…BACKGROUND TA‐90 is a tumor‐associated antigen first identified in the urine and sera of patients with metastatic melanoma. In the early stages of disease,…”
Get full text
Journal Article -
9
Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: an immunologic survival model
Published in Annals of surgical oncology (01-09-1996)“…Our polyvalent, allogeneic melanoma cell vaccine (MCV) induces immunoglobulin M (IgM) and immunoglobulin G (IgG) class antibodies to a 90-kDa glycoprotein…”
Get full text
Journal Article -
10
Serum TA90 immune complex assay can predict outcome after resection of thick (> or =4 mm) primary melanoma and sentinel lymphadenectomy
Published in Annals of surgical oncology (01-03-2002)“…We hypothesized that the postoperative serum level of TA90-IC, an immune complex of a 90-kDa tumor-associated antigen and its antibody, might have a…”
Get full text
Journal Article -
11
Positron emission tomography plus serum TA90 immune complex assay for detection of occult metastatic melanoma
Published in Journal of the American College of Surgeons (01-08-1998)“…Background: Whole-body positron emission tomography (PET) using 18F-fluorodeoxyglucose is very sensitive for detection of metastatic melanoma. We previously…”
Get full text
Journal Article Conference Proceeding -
12
Preoperative serum TA90-IC as an adjunct to serum CA 19-9 in the diagnosis of pancreatic malignancy: A pilot study
Published in Current surgery (01-03-2002)“…Because TA90, a 90-kDa immunogenic tumor-associated antigen, is expressed by pancreatic cancer cells, we hypothesized that the serum level of its immune…”
Get full text
Journal Article -
13
TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma
Published in The cancer journal from Scientific American (01-11-1997)“…Although prognosis remains poor for patients with distant metastatic melanoma, we have observed significantly prolonged survival in patients receiving our…”
Get more information
Journal Article